Wallentin et al. showed although the incidences of stroke, definite stent thrombosis, and bleeding in CYP2C19 LOF allele carriers are higher than those with no LOF allele, whereas these increases were not statistically significant [14]. This evidence concerns the gene CYP2C19 and stroke disorder.